| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
| Veids | Citi |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2017-03-02 11:18:24 |
| Periods | |
| Versijas komentārs | |
| Teksts |
Olainfarm will hold Investor Conference Webinar about financial results of 2016AS „Olainfarm” invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on March 7, 2017 at 16:00 (EET). To join the webinar please follow the instructions below. Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English. During the webinar Salvis Lapiņš will inform about AS “Olainfarm” latest activities and analyze the financial results of the fourth quarter 2016 and non-audited financial results of 12 months 2016. After the presentation investors are welcome to ask questions. Due to the limited webinar time, please send in your questions in advance till March 6 to e-mail: eva.dzerve@nasdaq.com. What is
webinar? How to join the
webinar? To join the webinar, we invite you to register via http://ej.uz/OLF_YE2016. You will be provided with the
webinar link and instructions to join webinar successfully. When
joining the webinar for the first time, you will be asked to
download the system application on your computer which will take
only few seconds. Join the webinar and be the first one to hear the news! JSC Olainfarm is one of the
biggest pharmaceutical companies in Latvia with more than 40 years
of experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 35 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia. |
| Pielikumi |
|